title: T cell function in chronic myeloid leukemia and its treatment with tyrosine kinase inhibitors--clues from and for sarcoidosis.
authors.forename: Maqsood
authors.initials: M
authors.lastname: Punekar
authors.forename: Jecko
authors.initials: J
authors.lastname: Thachil
authors.forename: Rahuman
authors.initials: R
authors.lastname: Salim
authors.forename: Sara
authors.initials: S
authors.lastname: Watmough
authors.forename: Richard E
authors.initials: RE
authors.lastname: Clark
mesh_terms: D005260:Female; D016044:Fusion Proteins, bcr-abl / Q000235:genetics; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000235:genetics / Q000276:immunology*; D008875:Middle Aged; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*; D011743:Pyrimidines / Q000627:therapeutic use; D017565:Sarcoidosis, Pulmonary / Q000175:diagnosis*; D013601:T-Lymphocytes / Q000502:physiology*; D016896:Treatment Outcome
chemical_list: D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D011505:Protein-Tyrosine Kinases; D016044:Fusion Proteins, bcr-abl; C498826:nilotinib